These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2517248)

  • 21. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
    Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal instability in chronic myeloid leukemia: Philadelphia breakpoints are irrespective to spontaneous breakage and fragile sites.
    Fundia AF; Acevedo SH; Larripa IB
    Haematologica; 2000 Oct; 85(10):1104-6. PubMed ID: 11025611
    [No Abstract]   [Full Text] [Related]  

  • 24. Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms.
    Gümüş G; Sunguroğlu A; Tükün A; Sayin DB; Bökesoy I
    Cancer Genet Cytogenet; 2002 Mar; 133(2):168-71. PubMed ID: 11943347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced expression of aphidicolin-induced common fragile sites in peripheral lymphocyte chromosomes of patients with B-cell chronic lymphocytic leukemia.
    Nayak BN; Ray M
    Cancer Genet Cytogenet; 1989 May; 39(1):99-102. PubMed ID: 2499414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
    Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
    Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
    [No Abstract]   [Full Text] [Related]  

  • 28. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
    Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
    Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid peroxidation in leukaemia.
    Ghalaut VS; Ghalaut PS; Singh S
    J Assoc Physicians India; 1999 Apr; 47(4):403-5. PubMed ID: 10778525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of fragile sites in childhood acute lymphoblastic leukemia patients and normal controls.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Aug; 79(4):329-34. PubMed ID: 2970424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites.
    Kuwano A; Kajii T
    Hum Genet; 1987 Jan; 75(1):75-8. PubMed ID: 3100418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.
    Glover TW; Berger C; Coyle J; Echo B
    Hum Genet; 1984; 67(2):136-42. PubMed ID: 6430783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.
    Hecht F; Glover TW
    Cancer Genet Cytogenet; 1984 Oct; 13(2):185-8. PubMed ID: 6434179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome fragile sites in Down syndrome patients.
    Tedeschi B; Vernole P; Caporossi D; Nicoletti B
    Am J Med Genet Suppl; 1990; 7():192-4. PubMed ID: 2149945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukemia and lymphoma].
    Kato M; Ogawa S
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():481-4. PubMed ID: 20979299
    [No Abstract]   [Full Text] [Related]  

  • 39. A guide to fragile sites on human chromosomes.
    Hecht F; Ramesh KH; Lockwood DH
    Cancer Genet Cytogenet; 1990 Jan; 44(1):37-45. PubMed ID: 2104573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New common fragile sites.
    Hecht F; Tajara EH; Lockwood D; Sandberg AA; Hecht BK
    Cancer Genet Cytogenet; 1988 Jul; 33(1):1-9. PubMed ID: 2454726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.